D. Boral Capital analyst Jason Kolbert initiated coverage of Nano-X Imaging (NNOX) with a Buy rating and $23 price target Nanox is at the forefront of transforming medical imaging with its disruptive Nanox.ARC technology, promising to make diagnostic imaging universally accessible, the analyst tells investors in a research note. The firm says Nanox delivers a cost-effective, compact, and scalable solution to address critical gaps in global healthcare.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NNOX:
- Nano X call volume above normal and directionally bullish
- Unusually active option classes on open January 3rd
- Nano-X Imaging Secures Shareholder Approval for Key Proposals
- Largest borrow rate increases among liquid names
- Nano-X Imaging’s (NNOX) Shares Surge on FDA Approval but Have Yet to Reach Profitability